Hostname: page-component-89b8bd64d-9prln Total loading time: 0 Render date: 2026-05-10T14:40:40.777Z Has data issue: false hasContentIssue false

Integrating mRNA vaccines into the attitudes toward genomics and precision medicine scale: A validation study with a sample of 4939 adults in the USA

Published online by Cambridge University Press:  24 March 2025

Jenine K. Harris
Affiliation:
Brown School, Washington University in St. Louis, USA
Erin D. Solomon
Affiliation:
Division of General Medicine & Geriatrics, Washington University in St Louis, USA
Kari Baldwin
Affiliation:
Division of General Medicine & Geriatrics, Washington University in St Louis, USA
Lauren L. Baker
Affiliation:
Division of General Medicine & Geriatrics, Washington University in St Louis, USA
Eu Gene Chin
Affiliation:
Rosemead School of Psychology, Biola University, USA
James M. DuBois*
Affiliation:
Division of General Medicine & Geriatrics, Washington University in St Louis, USA
*
Corresponding author: J.M. DuBois; Email: duboisjm@wustl.edu
Rights & Permissions [Opens in a new window]

Abstract

The attitudes toward genomics and precision medicine (AGPM) measure examines attitudes toward activities such as genetic testing, gene editing, and biobanking. This is a useful tool for research on the ethical, legal, and social implications of genomics, a major program within the National Institutes of Health. We updated the AGPM to explore controversies over mRNA vaccines. This brief report examines the factor structure of the updated AGPM using a sample of 4939 adults in the USA. The updated AGPM’s seven factors include health benefits, knowledge benefits, and concerns about the sacredness of life, privacy, gene editing, mRNA vaccines, and social justice.

Information

Type
Brief Report
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NC
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial licence (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Association for Clinical and Translational Science
Figure 0

Table 1. Comparison of two groups of participants who completed a survey on values and attitudes toward genomics and genomic healthcare (total n = 4939; survey year = 2023)

Figure 1

Figure 1. Distribution of 4939 participant responses to the attitudes toward genomics and precision medicine items in a survey on values and attitudes toward genomics and genomic healthcare (2023) grouped by factor.

Figure 2

Table 2. Exploratory factor analysis loadings for responses from 2460 survey participants who completed a survey on values and attitudes toward genomics and genomic healthcare (2023)